ATE45090T1 - Pharmazeutische zusammensetzung in oralen darreichungsformen. - Google Patents
Pharmazeutische zusammensetzung in oralen darreichungsformen.Info
- Publication number
- ATE45090T1 ATE45090T1 AT83307861T AT83307861T ATE45090T1 AT E45090 T1 ATE45090 T1 AT E45090T1 AT 83307861 T AT83307861 T AT 83307861T AT 83307861 T AT83307861 T AT 83307861T AT E45090 T1 ATE45090 T1 AT E45090T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- dosage form
- oral dosage
- microdoses
- phenoxypyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dental Preparations (AREA)
- Saccharide Compounds (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/455,396 US4434169A (en) | 1983-01-03 | 1983-01-03 | Pharmaceutical compositions and methods |
EP83307861A EP0116781B1 (de) | 1983-01-03 | 1983-12-22 | Pharmazeutische Zusammensetzung in oralen Darreichungsformen |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE45090T1 true ATE45090T1 (de) | 1989-08-15 |
Family
ID=23808634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT83307861T ATE45090T1 (de) | 1983-01-03 | 1983-12-22 | Pharmazeutische zusammensetzung in oralen darreichungsformen. |
Country Status (9)
Country | Link |
---|---|
US (1) | US4434169A (de) |
EP (1) | EP0116781B1 (de) |
JP (1) | JPS59134723A (de) |
AT (1) | ATE45090T1 (de) |
AU (1) | AU555496B2 (de) |
CA (1) | CA1201656A (de) |
DE (1) | DE3380294D1 (de) |
DK (1) | DK1084A (de) |
IE (1) | IE56399B1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4666926A (en) * | 1986-02-27 | 1987-05-19 | Warner-Lambert Company | Transdermal formulations |
US4760083A (en) * | 1986-04-10 | 1988-07-26 | E. I. Dupont De Nemours & Company | 3,3-disubstituted indolines |
US5173489A (en) * | 1986-04-10 | 1992-12-22 | The Dupont Merck Pharmaceutical Co. | α,α-disubstituted aromatics and heteroaromatics as cognition enhancers |
US4876259A (en) * | 1987-01-05 | 1989-10-24 | E. I. Du Pont De Nemours And Company | 3,3-disubstituted indolines |
US5232934A (en) * | 1992-07-17 | 1993-08-03 | Warner-Lambert Co. | Method for the treatment of psychomotor stimulant addiction |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4128555A (en) * | 1976-12-17 | 1978-12-05 | Warner-Lambert Company | 3-Phenoxypyridine monosulfate and a method for its production |
US4067983A (en) | 1976-12-17 | 1978-01-10 | Parke, Davis & Company | Pharmaceutical compositions and methods |
-
1983
- 1983-01-03 US US06/455,396 patent/US4434169A/en not_active Expired - Fee Related
- 1983-12-13 IE IE2939/83A patent/IE56399B1/xx unknown
- 1983-12-19 CA CA000443678A patent/CA1201656A/en not_active Expired
- 1983-12-20 AU AU22570/83A patent/AU555496B2/en not_active Ceased
- 1983-12-22 AT AT83307861T patent/ATE45090T1/de not_active IP Right Cessation
- 1983-12-22 EP EP83307861A patent/EP0116781B1/de not_active Expired
- 1983-12-22 DE DE8383307861T patent/DE3380294D1/de not_active Expired
- 1983-12-27 JP JP58244990A patent/JPS59134723A/ja active Pending
-
1984
- 1984-01-02 DK DK1084A patent/DK1084A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU555496B2 (en) | 1986-09-25 |
CA1201656A (en) | 1986-03-11 |
EP0116781B1 (de) | 1989-08-02 |
IE56399B1 (en) | 1991-07-17 |
DE3380294D1 (en) | 1989-09-07 |
AU2257083A (en) | 1984-07-05 |
IE832939L (en) | 1984-07-03 |
DK1084A (da) | 1984-07-04 |
US4434169A (en) | 1984-02-28 |
JPS59134723A (ja) | 1984-08-02 |
DK1084D0 (da) | 1984-01-02 |
EP0116781A1 (de) | 1984-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
LU90677I2 (fr) | Esomeprazole et ses sels et d-riv-s pharmaceutiquement acceptables (nexiam) | |
ATE108657T1 (de) | Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus. | |
KR890700125A (ko) | 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물 | |
IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
GR890100833A (en) | Process for the preparation of a compound with gastric inhibitopy effect | |
ES2028917T3 (es) | Un procedimiento para preparar una composicion farmaceutica inyectable estable. | |
ATE38151T1 (de) | Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung. | |
GB1487334A (en) | Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof | |
ATE45090T1 (de) | Pharmazeutische zusammensetzung in oralen darreichungsformen. | |
ATE13488T1 (de) | Gallium-chlorid, ein neues antikrebsmittel. | |
ATE36531T1 (de) | Verfahren zur herstellung von abgesetzten, basischen piroxicam-salzen auf einem pharmazeutisch annehmbaren traeger. | |
NO164958C (no) | Fremgangsmaate for fremstilling av dipyridamol-preparater med ph-uavhengig, regulert frigjoering. | |
ATE7911T1 (de) | Pharmazeutisch zulassbare salze von 4'-(9acridinylamino)methansulfon-m-anisid, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
GB1246727A (en) | Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids | |
DE3265827D1 (en) | Pharmaceutical composition of phosphonomicin in tablet form | |
IT1164217B (it) | Sali di calcio di amminoacidi o di loro derivati,aventi attivita' terapeutica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
EP0207514A3 (en) | 1,4-dihydropyridine derivatives, process for preparing them, pharmaceutical composition and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |